Evidence map›Paper›PMID 38978033›Full record

ReviewBMC health services research2024

Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges.

Yael R Lefkovits, Natalie Heriot, Alice Sporik, Sharnel Perera, Michael Friedlander, Cyril Dixon, Paul A Cohen, Yeh Chen Lee, Simon Hyde, Gary Richardson and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yael R LefkovitsRoyal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia. yael.lefkovits@mh.org.au.
Natalie HeriotSchool of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Melbourne, Australia.
Alice SporikSchool of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Melbourne, Australia.
Sharnel PereraSchool of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Melbourne, Australia.
Michael FriedlanderDepartment of Medical Oncology, University of New South Wales, Sydney, Australia.
Cyril DixonOvarian Cancer Australia, Melbourne, Victoria, Australia.
Paul A CohenDiscipline of Obstetrics and Gynaecology, Medical School, University of Western Australia, Crawley, Western Australia, Australia.
Yeh Chen LeeMedical Oncology Department, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Simon HydeDepartment of Gynaecological Oncology, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Gary RichardsonSzalmuk Family Department of Medical Oncology, Cabrini Research, Malvern, Victoria, Australia.
Penelope WebbQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Robert RomeClinical Institute of Obstetrics and Gynaecology, Epworth HealthCare, East Melbourne, Victoria, Australia.
Madeleine KingSchool of Psychology, University of Sydney, Sydney, NSW, Australia.
John ZalcbergSchool of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Melbourne, Australia.
Penelope SchofieldSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As medical treatment increasingly focuses on improving health-related quality of life, patient-reported outcome measures (PROMs) are an essential component of clinical research. The National Gynae-Oncology Registry (NGOR) is an Australian clinical quality registry. A suitable PROM was required for the NGOR ovarian cancer module to complement clinical outcomes and provide insights into outcomes important to patients. Our narrative review aimed to identify existing ovarian cancer-specific PROMs and ascertain which tool would be most appropriate for implementation into the NGOR ovarian cancer module.A literature review of Cochrane Library, Embase, MEDLINE and PubMed databases was performed to identify existing ovarian cancer-specific PROM tools. A steering committee was convened to (1) determine the purpose of, and criteria for our required PROM; and (2) to review the available tools against the criteria and recommend the most appropriate one for implementation within the NGOR.The literature review yielded five tools: MOST, EORTC QLQ-OV28, FACIT-O, NFOSI-18 and QOL-OVCA. All were developed and validated for use in clinical trials, but none had been validated for use in clinical quality registry. Our expert steering committee pre-determined purpose of a PROM tool for use within the NGOR was to enable cross-service comparison and benchmarking to drive quality improvements. They identified that while there was no ideal, pre-existing, ovarian cancer-specific PROM tool for implementation into the NGOR, on the basis of its psychometric properties, its available translations, its length and its ability to be adapted, the EORTC tool is most fit-for-purpose for integration into the NGOR.This process enabled identification of the tool most appropriate to provide insights into how ovarian cancer treatments impact patients' quality of life and permit benchmarking across health services.

Indexed as

Ovarian NeoplasmsPatient Reported Outcome MeasuresQuality of LifeRegistriesAustraliaFemaleHumansClinical quality registryGynaecological cancerOvarian cancerPatient reported outcome measuresQuality of life

Identifiers

PMID38978033
PMCPMC11232149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.